ScholarIQanswers from OpenAlex

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

PaperCitations, authors & open-access status

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina have?

ScholarIQcitation count

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina has 491 citations in the OpenAlex counts ScholarIQ stores.

When was Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina published?

ScholarIQyear

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina has 2011 year in the ScholarIQ index.

What is the open-access status of Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina?

ScholarIQoa status

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina has bronze oa status in the ScholarIQ index.

What is the DOI of Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina?

ScholarIQdoi

The DOI for Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina is on the source record.

What is the PMID of Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina?

ScholarIQpmid

The PMID for Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina is on the source record.

What is the OpenAlex record for Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina?

ScholarIQopenalex

The OpenAlex for Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial